ETOPOSIDE AS SINGLE AGENT AND IN COMBINATION CHEMOTHERAPY OF BRONCHOGENIC-CARCINOMA

被引：12

作者：

GOLDHIRSCH, A

JOSS, R

CAVALLI, F

BRUNNER, KW

机构：

[1] OSPED SAN GIOVANNI,DEPT ONCOL,BELLINZONA,SWITZERLAND

[2] INSELSPITAL,INST MED ONCOL,CH-3010 BERN,SWITZERLAND

来源：

CANCER TREATMENT REVIEWS | 1982年 / 9卷

关键词：

D O I：

10.1016/S0305-7372(82)80084-4

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：85 / 90

页数：6

共 14 条

[1]

BRUNNER KW, 1976, CANCER TREAT REP, V60, P1377

[2]

CASPER ES, 1979, CANCER TREAT REP, V63, P2107

[3]

CAVALLI F, 1978, CANCER TREAT REP, V62, P473

[4]

DEJAGER R, 1980, P AM ASSOC CANC RES, V21, P363

[5]

EAGAN RT, 1978, CANCER TREAT REP, V62, P843

[6] ETOPOSIDE (VP 16-213) - A NEW CYTOSTATIC DRUG WITH A HIGH EFFECTIVENESS AGAINST ANAPLASTIC SMALL-CELL BRONCHIAL-CARCINOMA, OTHER SOLID TUMORS, AND HEMOBLASTOSES [J].

GOLDHIRSCH, A ;

JOSS, R ;

CAVALLI, F ;

SONNTAG, RW ;

RYSSEL, HJ ;

BRUNNER, KW .

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1981, 106 (35) :1105-1109

[7]

GOLDHIRSCH A, 1980, P AM ASSOC CANC RES, V21, P449

[8]

JOSS R, SCHWEIZ MED WOCHENSC

[9]

MABEL JA, 1979, P AM ASSOC CANC RES, V20, P230

[10]

NISSEN NI, 1980, CANCER, V45, P232, DOI 10.1002/1097-0142(19800115)45:2<232::AID-CNCR2820450206>3.0.CO

← 1 2 →